• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应激性高血糖与非糖尿病和糖尿病患者中风的预后:一项系统综述

Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview.

作者信息

Capes S E, Hunt D, Malmberg K, Pathak P, Gerstein H C

机构信息

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

出版信息

Stroke. 2001 Oct;32(10):2426-32. doi: 10.1161/hs1001.096194.

DOI:10.1161/hs1001.096194
PMID:11588337
Abstract

BACKGROUND AND PURPOSE

"Stress" hyperglycemia may be associated with increased mortality and poor recovery in diabetic and nondiabetic patients after stroke. A systematic review and meta-analysis of the literature relating acute poststroke glucose levels to the subsequent course were done to summarize and quantify this relationship.

METHODS

A comprehensive literature search was done for cohort studies reporting mortality and/or functional recovery after stroke in relation to admission glucose level. Relative risks in hyperglycemic compared with normoglycemic patients with and without diabetes were calculated and meta-analyzed when possible.

RESULTS

Thirty-two studies were identified; relative risks for prespecified outcomes were reported or could be calculated in 26 studies. After stroke of either subtype (ischemic or hemorrhagic), the unadjusted relative risk of in-hospital or 30-day mortality associated with admission glucose level >6 to 8 mmol/L (108 to 144 mg/dL) was 3.07 (95% CI, 2.50 to 3.79) in nondiabetic patients and 1.30 (95% CI, 0.49 to 3.43) in diabetic patients. After ischemic stroke, admission glucose level >6.1 to 7.0 mmol/L (110 to 126 mg/dL) was associated with increased risk of in-hospital or 30-day mortality in nondiabetic patients only (relative risk=3.28; 95% CI, 2.32 to 4.64). After hemorrhagic stroke, admission hyperglycemia was not associated with higher mortality in either diabetic or nondiabetic patients. Nondiabetic stroke survivors whose admission glucose level was >6.7 to 8 mmol/L (121 to 144 mg/dL) also had a greater risk of poor functional recovery (relative risk=1.41; 95% CI, 1.16 to 1.73).

CONCLUSIONS

Acute hyperglycemia predicts increased risk of in-hospital mortality after ischemic stroke in nondiabetic patients and increased risk of poor functional recovery in nondiabetic stroke survivors.

摘要

背景与目的

“应激性”高血糖可能与糖尿病和非糖尿病患者卒中后的死亡率增加及恢复不良有关。对有关卒中后急性血糖水平与后续病程的文献进行了系统评价和荟萃分析,以总结和量化这种关系。

方法

对报告卒中后死亡率和/或功能恢复与入院血糖水平关系的队列研究进行全面的文献检索。计算高血糖患者与血糖正常患者(无论是否患有糖尿病)的相对风险,并在可能的情况下进行荟萃分析。

结果

共识别出32项研究;26项研究报告或能够计算预先设定结局的相对风险。在任何一种亚型(缺血性或出血性)卒中后,入院血糖水平>6至8 mmol/L(108至144 mg/dL)时,非糖尿病患者院内或30天死亡率的未调整相对风险为3.07(95%CI,2.50至3.79),糖尿病患者为1.30(95%CI,0.49至3.43)。缺血性卒中后,仅在非糖尿病患者中,入院血糖水平>6.1至7.0 mmol/L(110至126 mg/dL)与院内或30天死亡率风险增加相关(相对风险=3.28;95%CI,2.32至4.64)。出血性卒中后,入院高血糖在糖尿病或非糖尿病患者中均与较高死亡率无关。入院血糖水平>6.7至8 mmol/L(121至144 mg/dL)的非糖尿病卒中幸存者功能恢复不良的风险也更高(相对风险=1.41;95%CI,1.16至1.73)。

结论

急性高血糖预示非糖尿病患者缺血性卒中后院内死亡风险增加,以及非糖尿病卒中幸存者功能恢复不良风险增加。

相似文献

1
Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview.应激性高血糖与非糖尿病和糖尿病患者中风的预后:一项系统综述
Stroke. 2001 Oct;32(10):2426-32. doi: 10.1161/hs1001.096194.
2
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.应激性高血糖与糖尿病及非糖尿病心肌梗死患者死亡风险增加:一项系统综述
Lancet. 2000 Mar 4;355(9206):773-8. doi: 10.1016/S0140-6736(99)08415-9.
3
Sex-based differences in inflammatory predictors of outcomes in patients undergoing mechanical thrombectomy: an inverse probability weighting analysis.接受机械取栓治疗患者结局的炎症预测指标中的性别差异:逆概率加权分析
Ther Adv Neurol Disord. 2025 Jun 21;18:17562864251345719. doi: 10.1177/17562864251345719. eCollection 2025.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.替尔泊肽10毫克和15毫克与司美格鲁肽2.4毫克治疗2型糖尿病患者肥胖和超重的间接比较疗效与安全性
Diabetes Obes Metab. 2025 Jun 19. doi: 10.1111/dom.16508.
6
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.抗血栓治疗预防神经影像学检查发现的小血管疾病但无痴呆的患者认知能力下降。
Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD012269. doi: 10.1002/14651858.CD012269.pub2.
7
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
8
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.

引用本文的文献

1
Stress Hyperglycemia as a Prognostic Indicator of the Clinical Outcomes in Patients with Stroke: A Comprehensive Literature Review.应激性高血糖作为卒中患者临床结局的预后指标:一项综合文献综述
Biomedicines. 2025 Jul 28;13(8):1834. doi: 10.3390/biomedicines13081834.
2
The influence of stress hyperglycemia on consciousness disturbance and short- and long-term outcomes in stroke patients without documented diabetes: Differences between ischemic and hemorrhagic stroke.应激性高血糖对无糖尿病记录的卒中患者意识障碍及短期和长期预后的影响:缺血性卒中和出血性卒中的差异
PLoS One. 2025 Aug 26;20(8):e0331077. doi: 10.1371/journal.pone.0331077. eCollection 2025.
3
Stress Hyperglycemia Ratio Outperforms Glycemic Variability in Predicting Mortality Among Acute Myocardial Infarction Patients With Reduced Ejection Fraction: A Retrospective Cohort Study.
应激性高血糖比值在预测射血分数降低的急性心肌梗死患者死亡率方面优于血糖变异性:一项回顾性队列研究。
J Diabetes. 2025 Aug;17(8):e70122. doi: 10.1111/1753-0407.70122.
4
Stress Hyperglycemia Ratio and Hemoglobin to RDW Ratio in Predicting the Outcomes of Thrombolysis-Treated Stroke: A Retrospective Cohort Study.应激性高血糖比值和血红蛋白与红细胞分布宽度比值在预测溶栓治疗卒中结局中的作用:一项回顾性队列研究
Arch Acad Emerg Med. 2025 Aug 7;13(1):e65. doi: 10.22037/aaemj.v13i1. eCollection 2025.
5
Triglyceride Glucose Index and Stress Hyperglycemia are Important Factors for Predicting Early Neurological Deterioration in Isolated Acute Pontine Infarction.甘油三酯葡萄糖指数和应激性高血糖是孤立性急性脑桥梗死早期神经功能恶化的重要预测因素。
Brain Behav. 2025 Aug;15(8):e70746. doi: 10.1002/brb3.70746.
6
Association of admission blood glucose and postoperation fast blood glucose with futile recanalization in patients with endovascular therapy.血管内治疗患者入院血糖和术后空腹血糖与再通失败的相关性
BMC Neurol. 2025 Jul 30;25(1):313. doi: 10.1186/s12883-025-04344-9.
7
Baseline predictors of poor clinical outcome despite recanalization of distal middle cerebral artery occlusions.尽管大脑中动脉远端闭塞再通但临床预后不良的基线预测因素。
Interv Neuroradiol. 2025 Jul 16:15910199251342841. doi: 10.1177/15910199251342841.
8
Association between stress hyperglycemia ratio (SHR) and the risk of acute kidney injury in patients with chronic kidney disease: analysis of the MIMIC-IV database.慢性肾脏病患者应激性高血糖比值(SHR)与急性肾损伤风险的关联:MIMIC-IV数据库分析
BMC Nephrol. 2025 Jul 1;26(1):310. doi: 10.1186/s12882-025-04212-1.
9
Screening for Post-Stroke Cognitive Impairment in Sub-Saharan Africa: A Good IDEA?撒哈拉以南非洲地区中风后认知障碍的筛查:一个好主意?
Brain Sci. 2025 May 22;15(6):543. doi: 10.3390/brainsci15060543.
10
Relationship Between Systemic and Cerebral Microdialysate Glucose in Patients With Severe Acute Brain Injury-A Retrospective Study.重症急性脑损伤患者全身与脑微透析液葡萄糖之间的关系——一项回顾性研究
Acta Anaesthesiol Scand. 2025 Jul;69(6):e70078. doi: 10.1111/aas.70078.